ANG Lifesciences India Board Meeting Scheduled on 14th Nov'26 for Q2 Results
ANG Lifesciences India Ltd 路 Intimation 路 14 Nov 2026, 5:30 am
ANG Lifesciences India Board Meeting Scheduled on 14th Nov'26 for Q2 Results ANG Lifesciences India Ltd has notified BSE that its Board of Directors will meet on 14th Nov'26 to consider and approve the standalone and consolidated unaudited financial results for the quarter and half-year ended 30th Sep'26. Additionally, the insider trading window, which has been closed since 1st Oct'26, will remain shut until 48 hours after the public announcement of the financial results.
Original exchange filing (PDF)
More announcements from ANG Lifesciences India Ltd
- Cessation of Independent Director upon completion of tenure. 路 18 Nov 2026
- Appointment of Mrs. Preeti Sarin as Additional Independent Director of the Company 路 15 Nov 2026
- Financial Results for the quarter and half year ended 30.09.2026. 路 15 Nov 2026
- Approval of Unaudited Financial Results for the quarter and half year ended 30-09-2026. 路 15 Nov 2026
- Scrutinizer''s Report for AGM along with Voting Results 路 01 Oct 2026
- Re-appointment of Ms. Chetna as the Independent Director of the company. 路 30 Sept 2026
- Proceedings of 20th Annual General Meeting are enclosed herewith. 路 30 Sept 2026
- Pursuant to Regulations 30 and 34 of the SEBI (LODR) Regulations, 2015, as amended ('''' Listing Regulations''''), please find attached herewith the Annual Report of the Company for the .... 路 08 Sept 2026
